{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T02:54:14Z","timestamp":1789440854097,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ejphar.2022.174846","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T03:02:36Z","timestamp":1645498956000},"page":"174846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Novel oral edaravone attenuates diastolic dysfunction of diabetic cardiomyopathy by activating the Nrf2 signaling pathway"],"prefix":"10.1016","volume":"920","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7451-6876","authenticated-orcid":false,"given":"Ling","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Qin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Hua","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Hui","family":"Cang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Xuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-xia","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2873-7210","authenticated-orcid":false,"given":"Li-Jin","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Yun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Fu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2022.174846_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10741-013-9388-5","article-title":"Structural changes in the myocardium during diabetes-induced cardiomyopathy","volume":"19","author":"Adeghate","year":"2014","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.ejphar.2022.174846_bib2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1248\/cpb.48.467","article-title":"Quantitative analysis of the kinetic constant of the reaction of N,N'-propylenedinicotinamide with the hydroxyl radical using dimethyl sulfoxide and deduction of its structure in chloroform","volume":"48","author":"Akimoto","year":"2000","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.ejphar.2022.174846_bib4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.yjmcc.2013.01.008","article-title":"Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation","volume":"57","author":"Bai","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2022.174846_bib5","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00099-20","article-title":"The molecular mechanisms regulating the KEAP1-NRF2 pathway","volume":"40","author":"Baird","year":"2020","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2022.174846_bib7","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbamcr.2018.02.010","article-title":"Nrf2-Keap1 signaling in oxidative and reductive stress","volume":"1865","author":"Bellezza","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.ejphar.2022.174846_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1152\/physiolgenomics.00041.2017","article-title":"Nrf2 at the heart of oxidative stress and cardiac protection","volume":"50","author":"Chen","year":"2018","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.ejphar.2022.174846_bib9","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.cellsig.2015.06.009","article-title":"The alpha1-adrenergic receptors in cardiac hypertrophy: signaling mechanisms and functional implications","volume":"27","author":"Cotecchia","year":"2015","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejphar.2022.174846_bib10","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/CIRCRESAHA.118.314665","article-title":"Diabetic cardiomyopathy","volume":"124","author":"Dillmann","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2022.174846_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133264","article-title":"Molecular dysfunction and phenotypic derangement in diabetic cardiomyopathy","volume":"20","author":"Evangelista","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2022.174846_bib12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10741-011-9257-z","article-title":"Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment","volume":"17","author":"Falc\u00e3o-Pires","year":"2012","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.ejphar.2022.174846_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/md17050285","article-title":"Edaravone-loaded alginate-based nanocomposite hydrogel accelerated chronic wound healing in diabetic mice","volume":"17","author":"Fan","year":"2019","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejphar.2022.174846_bib14","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/CIRCRESAHA.117.311401","article-title":"Reactive oxygen species in metabolic and inflammatory signaling","volume":"122","author":"Forrester","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2022.174846_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6657529","article-title":"Inactivation of TOPK caused by hyperglycemia blocks diabetic heart sensitivity to sevoflurane postconditioning by impairing the PTEN\/PI3K\/akt signaling","volume":"2021","author":"Gao","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2022.174846_bib18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2337\/db15-1274","article-title":"Metallothionein is downstream of Nrf2 and partially mediates sulforaphane prevention of diabetic cardiomyopathy","volume":"66","author":"Gu","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2022.174846_bib20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.pharmthera.2014.01.003","article-title":"Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways","volume":"142","author":"Huynh","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2022.174846_bib21","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.mam.2011.10.006","article-title":"Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation","volume":"32","author":"Hybertson","year":"2011","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.ejphar.2022.174846_bib22","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1124\/jpet.108.148676","article-title":"Edaravone, a free radical scavenger, protects against retinal damage in vitro and in vivo","volume":"329","author":"Inokuchi","year":"2009","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2022.174846_bib23","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2022.174846_bib24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","article-title":"Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease","volume":"61","author":"Jia","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2022.174846_bib25","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1073\/pnas.1422998112","article-title":"Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits","volume":"112","author":"Jiao","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2022.174846_bib26","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.bmcl.2014.01.045","article-title":"A multiple free-radical scavenging (MULTIS) study on the antioxidant capacity of a neuroprotective drug, edaravone as compared with uric acid, glutathione, and trolox","volume":"24","author":"Kamogawa","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejphar.2022.174846_bib27","doi-asserted-by":"crossref","first-page":"13909","DOI":"10.3390\/ijms140713909","article-title":"The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease","volume":"14","author":"Kikuchi","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2022.174846_bib28","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00004647-199907000-00008","article-title":"Neuroprotective effects of a novel nitrone, NXY-059, after transient focal cerebral ischemia in the rat","volume":"19","author":"Kuroda","year":"1999","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.ejphar.2022.174846_bib31","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/jcmm.14870","article-title":"Allopurinol reduces oxidative stress and activates Nrf2\/p62 to attenuate diabetic cardiomyopathy in rats","volume":"24","author":"Luo","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2022.174846_bib32","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","article-title":"Role of nrf2 in oxidative stress and toxicity","volume":"53","author":"Ma","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2022.174846_bib33","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3732718","article-title":"Bakuchiol alleviates hyperglycemia-induced diabetic cardiomyopathy by reducing myocardial oxidative stress via activating the SIRT1\/nrf2 signaling pathway","volume":"2020","author":"Ma","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2022.174846_bib35","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jacc.2017.11.019","article-title":"Implications of underlying mechanisms for the recognition and management of diabetic cardiomyopathy","volume":"71","author":"Marwick","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2022.174846_bib36","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2022.174846_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051197","article-title":"Molecular mechanisms responsible for diastolic dysfunction in diabetes mellitus patients","volume":"20","author":"Nikolajevic Starcevic","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2022.174846_bib39","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.mayocp.2018.04.007","article-title":"Amyotrophic lateral sclerosis: an update for 2018","volume":"93","author":"Oskarsson","year":"2018","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ejphar.2022.174846_bib40","first-page":"1407","article-title":"Edaravone attenuates experimental asthma in mice through induction of HO-1 and the Keap1\/Nrf2 pathway","volume":"19","author":"Pan","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejphar.2022.174846_bib41","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.hfc.2019.02.003","article-title":"Diabetic cardiomyopathy: definition, diagnosis, and therapeutic implications","volume":"15","author":"Paolillo","year":"2019","journal-title":"Heart Fail. Clin."},{"key":"10.1016\/j.ejphar.2022.174846_bib42","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s13346-018-0543-3","article-title":"Curcumin-loaded self-nanomicellizing solid dispersion system: part I: development, optimization, characterization, and oral bioavailability","volume":"8","author":"Parikh","year":"2018","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejphar.2022.174846_bib43","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1080\/10717544.2017.1337825","article-title":"Lipid-based nanosystem of edaravone: development, optimization, characterization and in vitro\/in vivo evaluation","volume":"24","author":"Parikh","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejphar.2022.174846_bib44","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1161\/CIRCULATIONAHA.119.043053","article-title":"Single-cell reconstruction of progression trajectory reveals intervention principles in pathological cardiac hypertrophy","volume":"141","author":"Ren","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2022.174846_bib47","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2022.174846_bib49","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/jdi.12235","article-title":"Modeling type 2 diabetes in rats using high fat diet and streptozotocin","volume":"5","author":"Skovso","year":"2014","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.ejphar.2022.174846_bib50","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1254\/jphs.SC0060170","article-title":"Effects of edaravone on singlet oxygen released from activated human neutrophils","volume":"103","author":"Sommani","year":"2007","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2022.174846_bib52","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","article-title":"Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence","volume":"17","author":"Tan","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ejphar.2022.174846_bib53","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.2174\/0929867324666170705111356","article-title":"Clinical approach to diabetic cardiomyopathy: a review of human studies","volume":"25","author":"Tarquini","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejphar.2022.174846_bib56","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCULATIONAHA.107.728550","article-title":"Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension","volume":"117","author":"van Heerebeek","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2022.174846_bib57","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4196\/kjpp.2016.20.4.333","article-title":"Effect of edaravone in diabetes mellitus-induced nephropathy in rats","volume":"20","author":"Varatharajan","year":"2016","journal-title":"KOREAN J. PHYSIOL. PHARMACOL."},{"key":"10.1016\/j.ejphar.2022.174846_bib58","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s12265-020-10083-8","article-title":"NRF2 in cardiovascular diseases: a ray of hope","volume":"14","author":"Vashi","year":"2020","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.ejphar.2022.174846_bib59","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00125-010-1682-3","article-title":"Diastolic dysfunction in diabetes and the metabolic syndrome: promising potential for diagnosis and prognosis","volume":"53","author":"von Bibra","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2022.174846_bib60","first-page":"17","article-title":"Edaravone protects from retinal injury through NF-\u03baB in diabetic rats","volume":"23","author":"Wan","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2022.174846_bib61","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.redox.2017.12.016","article-title":"Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 via stimulating the Akt\/GSK-3\u00df\/Fyn pathway","volume":"15","author":"Xin","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2022.174846_bib62","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/13510002.1996.11747069","article-title":"Antioxidant activity of 3-methyl-1-phenyl-2-pyrazolin-5-one","volume":"2","author":"Yamamoto","year":"1996","journal-title":"Redox Rep."},{"key":"10.1016\/j.ejphar.2022.174846_bib63","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3892\/ijo.2020.5077","article-title":"Protective effects of combined treatment with mild hypothermia and edaravone against cerebral ischemia\/reperfusion injury via oxidative stress and Nrf2 pathway regulation","volume":"57","author":"Yu","year":"2020","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejphar.2022.174846_bib64","article-title":"Edaravone protect against retinal damage in streptozotocin-induced diabetic mice","volume":"9","author":"Yuan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2022.174846_bib65","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.08.019","article-title":"Edaravone reduces iron-mediated hydrocephalus and behavioral disorder in rat by activating the Nrf2\/HO-1 pathway","volume":"27","author":"Zhang","year":"2018","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.ejphar.2022.174846_bib66","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12933-018-0803-z","article-title":"Alogliptin prevents diastolic dysfunction and preserves left ventricular mitochondrial function in diabetic rabbits","volume":"17","author":"Zhang","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejphar.2022.174846_bib67","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/heartjnl-2017-311652","article-title":"Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis","volume":"104","author":"Zheng","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.ejphar.2022.174846_bib68","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/1394486","article-title":"Mitoquinone protects podocytes from angiotensin II-induced mitochondrial dysfunction and injury via the keap1-nrf2 signaling pathway","volume":"2021","author":"Zhu","year":"2021","journal-title":"Oxid. Med. Cell. Longev."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922001078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922001078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T23:00:56Z","timestamp":1757977256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299922001078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":53,"alternative-id":["S0014299922001078"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.174846","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-936670\/v1","asserted-by":"object"}]},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel oral edaravone attenuates diastolic dysfunction of diabetic cardiomyopathy by activating the Nrf2 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.174846","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"174846"}}